Regenerative medicine companies financings 2022

Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.

This statistic depicts the capital raised by regenerative medicine companies worldwide from 2016 to 2022, measured in million U.S. dollars. In 2022, the total amount raised by this industry stood at 12.6 billion U.S. dollars.

Capital raised by regenerative medicine companies worldwide from 2016 to 2022 (in million U.S. dollars)

Characteristic	2016	2017	2018	2019	2020*	2021**	2022*
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

January 2023

More information

Region

Worldwide

Survey time period

2016 to 2022

Supplementary notes

Total amount raised represents sector-wide figures; some companies are active in more than one technology group. Data does not include M&A transactions.
All values are rounded; sums may not add up to shown totals.
This statistic was assembled from several ARM State of the Industry reports.
* The report included only the total amount.
** In 2021, cell therapy is reported as cell-based IO (immuno-oncology) and cell therapy.

Citation formats